Rongfeng Fu

12PUBLICATIONS
37CO-AUTHORS
AutoimmunityTissue engineeringMedical biotechnology not elsewhere classifiedInfant and child healthCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 29, 2026
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial.

|Mar 12, 2026
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity.

Wei Liu, Xiaolei Pei, Tenghui Yu

|Oct 27, 2024
Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa-2b.

Shanshan Suo, Rong Feng Fu, Albert Qin

|Oct 07, 2024
Childhood and adolescent essential thrombocythemia and prefibrotic primary myelofibrosis: insights into diagnosis, outcomes, and treatment from a large Chinese cohort.

Rongfeng Fu, Huan Dong, Wenjing Gu

|Sep 27, 2024
Reduced Platelet Activation in Triple-Negative Essential Thrombocythemia Compared with JAK2V617F-Mutated Essential Thrombocythemia.

Huan Dong, Jia Chen, Jing Zhang

|Sep 10, 2024
Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study.

Qing Wen, Ting Sun, Jia Chen

Pageof 2

Frequent Collaborators

12 joint publications

Lei Zhang

8 joint publications

Yunfei Chen

6 joint publications

Feng Xue

5 joint publications

Wei Liu